Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Colavita

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
The Journal of Rheumatology|March 3, 2018
Human Osteoblast-like Cells Are Permissive for Zika Virus ReplicationFrancesca Colavita, Giuseppina Musumeci, Claudia Caglioti
JAMA Ophthalmology|July 29, 2021
Live and Replication-Competent SARS-CoV-2 in Ocular FluidsFrancesca Colavita, Salvatore Curiale, Daniele Lapa, et al.
Viruses|February 27, 2026
SARS-CoV-2 Persistence and the Gut Microbiota: New Insights into Long COVID PathogenesisSofia De Stefanis, Francesca Colavita, Fabrizio Maggi, et al.
The Lancet. Infectious Diseases|December 9, 2024
Prolonged detection of Oropouche virus RNA in whole blood samplesFrancesca Colavita, Fabrizio Carletti, Alessandra D'Abramo, et al.
Reviews in Medical Virology|March 10, 2025
Oropouche Virus: Implications for Transfusion ServicesDaniele Focosi, Francesca Colavita, Silvia Meschi, et al.
The Journal of Infection|October 5, 2024
Mpox Immune response elicited by MVA-BN vaccine over 12 months of follow-upGiulia Matusali, Eleonora Cimini, Valentina Mazzotta, et al.
Transfusion|August 10, 2024
Incidentally detected West Nile virus-RNA positive blood donors do not harbor high titers of neutralizing antibodiesSilvia Meschi, Francesca Colavita, Giulia Matusali, et al.
Biosensors & Bioelectronics|February 16, 2023
Biomimetic nanoplasmonic sensor for rapid evaluation of neutralizing SARS-CoV-2 monoclonal antibodies as antiviral therapyRazia Batool, Maria Soler, Francesca Colavita, et al.
Antiviral Research|September 19, 2012
Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt's lymphoma cells by affecting multiple molecular targetsAlessandra De Leo, Giuseppe Arena, Egidio Lacanna, et al.
The Lancet. Infectious Diseases|October 2, 2022
Monkeypox virus in human body sites and fluids: evidence for transmissionFrancesca Colavita, Andrea Antinori, Emanuele Nicastri, et al.
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
The Journal of Rheumatology|March 3, 2018
Human Osteoblast-like Cells Are Permissive for Zika Virus ReplicationFrancesca Colavita, Giuseppina Musumeci, Claudia Caglioti
JAMA Ophthalmology|July 29, 2021
Live and Replication-Competent SARS-CoV-2 in Ocular FluidsFrancesca Colavita, Salvatore Curiale, Daniele Lapa, et al.
Viruses|February 27, 2026
SARS-CoV-2 Persistence and the Gut Microbiota: New Insights into Long COVID PathogenesisSofia De Stefanis, Francesca Colavita, Fabrizio Maggi, et al.
The Lancet. Infectious Diseases|December 9, 2024
Prolonged detection of Oropouche virus RNA in whole blood samplesFrancesca Colavita, Fabrizio Carletti, Alessandra D'Abramo, et al.
Reviews in Medical Virology|March 10, 2025
Oropouche Virus: Implications for Transfusion ServicesDaniele Focosi, Francesca Colavita, Silvia Meschi, et al.
The Journal of Infection|October 5, 2024
Mpox Immune response elicited by MVA-BN vaccine over 12 months of follow-upGiulia Matusali, Eleonora Cimini, Valentina Mazzotta, et al.
Transfusion|August 10, 2024
Incidentally detected West Nile virus-RNA positive blood donors do not harbor high titers of neutralizing antibodiesSilvia Meschi, Francesca Colavita, Giulia Matusali, et al.
Biosensors & Bioelectronics|February 16, 2023
Biomimetic nanoplasmonic sensor for rapid evaluation of neutralizing SARS-CoV-2 monoclonal antibodies as antiviral therapyRazia Batool, Maria Soler, Francesca Colavita, et al.
Antiviral Research|September 19, 2012
Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt's lymphoma cells by affecting multiple molecular targetsAlessandra De Leo, Giuseppe Arena, Egidio Lacanna, et al.
The Lancet. Infectious Diseases|October 2, 2022
Monkeypox virus in human body sites and fluids: evidence for transmissionFrancesca Colavita, Andrea Antinori, Emanuele Nicastri, et al.
Pageof 13